Intellia updates bylaws on notices and forums
Intellia Therapeutics, Inc. amended its bylaws, effective April 7, 2026.
Rhea-AI Filing Summary
Intellia Therapeutics, Inc. amended its bylaws, effective April 7, 2026. The changes let shareholders fix facially obvious errors in timely notices of director nominations or other proposals, and require the company to alert them when such deficiencies exist so they can be cured.
The updated bylaws also make federal district courts in the United States the exclusive forum for complaints asserting causes of action under the Securities Act of 1933 or the Securities Exchange Act of 1934, unless Intellia agrees in writing to a different forum.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 5.03, 9.01
2 items
Item 5.03
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Terms
Fourth Amended and Restated By-laws, facially apparent deficiencies, exclusive forum, Securities Act of 1933, +1 more
5 terms
Fourth Amended and Restated By-laws regulatory
"Under the Fourth Amended and Restated By-laws, which are effective April 7, 2026"
facially apparent deficiencies regulatory
"allowing shareholders to cure any facially apparent deficiencies in a shareholder’s timely notice"
exclusive forum regulatory
"designate the federal district courts of the United States as the exclusive forum for resolving any complaint"
Securities Act of 1933 regulatory
"arising under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934"
Securities Exchange Act of 1934 regulatory
"or the Securities Exchange Act of 1934, as amended, or the respective rules and regulations"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Intellia Therapeutics (NTLA) change in its bylaws on April 7, 2026?
Intellia Therapeutics updated its bylaws to let shareholders cure facially apparent errors in timely nomination or proposal notices and to require the company to notify them of such deficiencies, while also revising where certain securities law complaints must be filed.
What is the new exclusive forum provision in Intellia Therapeutics’ bylaws?
The amended bylaws designate U.S. federal district courts as the exclusive forum for complaints asserting causes of action under the Securities Act of 1933 or the Securities Exchange Act of 1934, unless Intellia consents in writing to an alternative forum for such disputes.
Do Intellia’s amended bylaws change where Securities Act claims can be brought?
Yes. Under the revised bylaws, complaints asserting causes of action under the Securities Act of 1933 generally must be brought in U.S. federal district courts, unless Intellia agrees in writing to a different forum, centralizing these securities law disputes at the federal level.
When did Intellia’s Fourth Amended and Restated By-laws become effective?
Intellia’s Fourth Amended and Restated By-laws became effective on April 7, 2026. The board of directors approved these amendments following a recommendation from its nominating and corporate governance committee, and they are now the governing bylaws for the company.
Where can investors find the full text of Intellia’s amended bylaws?
The complete text of Intellia’s Fourth Amended and Restated By-laws is included as Exhibit 3.1 to the current report on Form 8-K. The filing states that the brief summary is qualified in its entirety by reference to this full exhibit document.
AI-generated analysis. How Rhea-AI works. Not financial advice.
